- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06838936
Binaural Beats Dysmenorrhea And Sleep Quality
June 30, 2025 updated by: Seda Hazar, Inonu University
The Effect of Binaural Beats on Sleep Quality and Dysmenorrhea During Menstruation
The research is a randomized controlled trial.
The sample group will consist of 120 people; 60 participants will be included in the experimental group, and 60 will be included in the control group.
In the study, the participants in the experimental group will listen to the alpha sound for pain for 10 minutes and the delta sound for sleep for 15 minutes via the mobile application three days a week.
The researchers will not intervene with the control group during the study.
During the study, only the data collection tabs of the mobile application will be active for the control group, and the use of the sounds will be opened at the end of the study.
The study data were used in the personal identification form, menstruation symptom scale, Pittsburgh sleep quality index, and Women's Health Initiative Insomnia Scale.
Study Overview
Detailed Description
Binaural beats are based on creating a physiological response by applying sound at different frequencies to both ears.
The brain perceives the sound given at different frequencies to both ears as a single frequency.
The perception of different frequency sounds as a single frequency is called binaural integration.
EEG studies suggest that binaural beats can affect electrocortical activity; that is, they can modulate the frequency of neuronal oscillations without requiring prior training.
Binaural beats application reduces pain, anxiety, and stress and improves sleep quality in individuals.
Binaural beats is a non-pharmacological application that does not require any training before application.
No side effects have been reported in the studies conducted in the literature, and it is also emphasized that it is an effective, cheap, safe, and non-pharmacological application.
From this point of view, this study aims to determine the effect of binaural beats on sleep quality and dysmenorrhea during menstruation.
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Malatya, Turkey, 44280
- Inonu University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Being over 18 years old
- Having headphones (for the experimental group)
- Having pain of 4 and above according to the numerical pain scale
- Taking a Women's Health and Diseases Nursing Course
- Not using medication during menstruation
- Not using sleeping pills
- Being single
- Not using contraceptives
- Not having a hearing problem
- Not having a psychiatric problem
- Not having alcohol or substance addiction constitutes the inclusion criteria of the study.
Exclusion Criteria:
- Not listening to binaural sounds for two days or more on the days specified in the mobile application
- Using analgesics during menstruation while the study is ongoing
- Experiencing irregular menstrual bleeding in the last three months constitutes the study's exclusion criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
|
|
|
Experimental: Interventional group
Mobil application (binaural beats)
|
Mobile application for binaural beats listening
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Rating Scale
Time Frame: up to six months
|
The Numerical Pain Scale is the most commonly used and easiest to measure scale for pain assessment.
No pain is given 0 (zero), and unbearable pain is given 10 (ten) points.
|
up to six months
|
|
Menstrual Symptom Questionnaire
Time Frame: up to six months
|
It was developed by Chesney and Tasto in 1975 to assess menstrual pain and symptoms.
The scale, which is a five-point Likert type and consists of 24 items, was updated by Negriff et al. in 2009.
The MSÖ score is calculated by taking the total score average of the items in the scale.
An increase in the score average indicates that the severity of menstrual symptoms increases.
The scale consists of 22 items and a total of three sub-dimensions.
On the scale, participants give a value between one and five (1=never, 2=sometimes, 3=occasionally, 4=often, 5=always) to the symptoms they experience related to menstruation.
The score obtained from the sub-dimensions in the scale is calculated by taking the total score average of the items in the sub-dimensions.
An increase in the scoring average for the sub-dimensions indicates that the severity of menstrual symptoms related to that sub-dimension increases.
|
up to six months
|
|
Pittsburgh Sleep Quality Index
Time Frame: up to six months
|
The Pittsburgh Sleep Quality Index was developed in 1988 to determine sleep quality.
It consists of 7 components with a total of 24 questions.
These components are subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping pills and daytime dysfunction.
The sum of the scores of all components gives the PSQI score.
The 10th and 11th questions in the index are not included in the calculation.
Scores of 5 and above indicate poor sleep quality, and as the score received on the scale increases, sleep quality worsens.
The index was studied for reliability and validity by Ağargün et al (1996) and its internal consistency was found to be 0.80.
|
up to six months
|
|
Women's Health Initiative Insomnia Scale
Time Frame: up to six months
|
The validity and reliability study of the scale developed by Levine et al. (2003) was conducted in our country by Timur and Şahin (2009).
The scale is a Likert-type scale consisting of 5 questions.
The first four questions in the scale determine the onset of insomnia, inability to maintain sleep, and early morning awakening.
The last question is related to sleep quality.
The answer to each question is based on the individual's experiences in the last 4 weeks and considering the frequency of each week.
|
up to six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2024
Primary Completion (Actual)
January 30, 2025
Study Completion (Actual)
May 15, 2025
Study Registration Dates
First Submitted
January 19, 2025
First Submitted That Met QC Criteria
February 20, 2025
First Posted (Actual)
February 21, 2025
Study Record Updates
Last Update Posted (Estimated)
July 1, 2025
Last Update Submitted That Met QC Criteria
June 30, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Nursing Department
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Indivual participant data (IPD) will not be avaliable to other researchers, they will be kept secret.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dysmenorrhea Primary
-
Ankara UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruiting
-
University of SharjahNot yet recruiting
-
Cairo UniversityRecruitingPrimary DysmenorrheaEgypt
-
Cairo UniversityCompletedPrimary DysmenorrheaEgypt
-
Camilo Jose Cela UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingPrimary DysmenorrheaEgypt
-
Rana Salem Abdelghany AliCompletedPrimary DysmenorrheaEgypt
-
University of HailHealth Education Research Foundation (HERF)Recruiting
-
Dr. Mehak NaeemUniversity of Health Sciences LahoreRecruiting
-
ApexCPG LLCNot yet recruitingPrimary Dysmenorrhea | Menstural CrampsIndia
Clinical Trials on Binaural Beats
-
Psychiatric Hospital of the CrossCompletedSchizophenia DisorderLebanon
-
Seoul National University HospitalNot yet recruitingEmergence DeliriumKorea, Republic of
-
Federal University of PiauiCompletedCybersickness | Reduced SensationBrazil
-
Chang Gung Memorial HospitalRecruiting
-
Azienda USL Toscana Nord OvestCompletedPostoperative Pain | Anxiety | Morphine ConsumptionItaly
-
Seoul National University HospitalRecruitingCataract | Geriatric Anesthesia | Binaural BeatsSouth Korea
-
Alexandria UniversityCompleted
-
China Medical University, TaiwanRecruiting
-
University of MiamiRecruitingAnxiety | Total Knee Arthroplasty | Total Hip Replacement | Total Knee Replacement | Total Hip Arthroplasty (THA) | THA | Music Exposure | TKA | Binaural BeatsUnited States